Rosen, a top ranked law firm, encourages kyverna therapeutics, inc. investors to secure counsel before important deadline in securities class action – kytx

New york, dec. 20, 2024 (globe newswire) -- why: rosen law firm, a global investor rights law firm, reminds purchasers of common stock of kyverna therapeutics, inc. (nasdaq: kytx) pursuant and/or traceable to the kyverna's initial public offering conducted on february 8, 2024 (the “ipo”), of the important february 7, 2025 lead plaintiff deadline.
TOP Ratings Summary
TOP Quant Ranking